CURRENT TREATMENT OPTIONS IN ONCOLOGY

Journal Title
CURRENT TREATMENT OPTIONS IN ONCOLOGY

CURR TREAT OPTION ON

ISSN / eISSN
1527-2729 / 1534-6277
Aims and Scope
This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
Subject Area

ONCOLOGY

CiteScore
7.10 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Pharmacology (medical) Q1 #53/272
Medicine - Oncology Q1 #93/404
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
ONCOLOGY Q2
H-index
48
Country/Area of Publication
US
Publisher
Springer US
Publication Frequency
Bimonthly
Year Publication Started
2000
Annual Article Volume
114
Open Access
NO
Contact
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More